PE20081197A1 - Sistema de liberacion lenta a corto plazo de drogas - Google Patents
Sistema de liberacion lenta a corto plazo de drogasInfo
- Publication number
- PE20081197A1 PE20081197A1 PE2007001676A PE2007001676A PE20081197A1 PE 20081197 A1 PE20081197 A1 PE 20081197A1 PE 2007001676 A PE2007001676 A PE 2007001676A PE 2007001676 A PE2007001676 A PE 2007001676A PE 20081197 A1 PE20081197 A1 PE 20081197A1
- Authority
- PE
- Peru
- Prior art keywords
- drugs
- short
- composition
- release system
- amount
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 abstract 1
- 229960000571 acetazolamide Drugs 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 235000013869 carnauba wax Nutrition 0.000 abstract 1
- 239000004203 carnauba wax Substances 0.000 abstract 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 abstract 1
- 229960003883 furosemide Drugs 0.000 abstract 1
- 159000000011 group IA salts Chemical class 0.000 abstract 1
- 229960002003 hydrochlorothiazide Drugs 0.000 abstract 1
- 229960005336 magnesium citrate Drugs 0.000 abstract 1
- 239000004337 magnesium citrate Substances 0.000 abstract 1
- 235000002538 magnesium citrate Nutrition 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 239000004584 polyacrylic acid Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 abstract 1
- 235000015497 potassium bicarbonate Nutrition 0.000 abstract 1
- 239000011736 potassium bicarbonate Substances 0.000 abstract 1
- 229940094025 potassium bicarbonate Drugs 0.000 abstract 1
- 229960002635 potassium citrate Drugs 0.000 abstract 1
- 239000001508 potassium citrate Substances 0.000 abstract 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 abstract 1
- 235000011082 potassium citrates Nutrition 0.000 abstract 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UN SISTEMA DE LIBERACION LENTA A CORTO PLAZO DE DROGAS PARA FORMAS FARMACEUTICAS ORALES SOLIDAS DE SALES ALCALINAS HIDROSOLUBLES DE METALES ALCALINOS Y METALES ALCALINO-TERREOS QUE COMPRENDEN: A) POLIVINILPIRROLIDONA EN UNA CANTIDAD DE 1,0% A 25% EN PESO DE LA COMPOSICION; B) UN ACIDO POLIACRILICO ENTRECUZADO EN UNA CANTIDAD DE 0,5% A 10% EN PESO DE LA COMPOSICION; C) UNA CERA TAL COMO LA CERA DE CARNAUBA EN UNA CANTIDAD DE 8% A 16% EN PESO DE LA COMPOSICION; D) UN PRINCIPIO ACTIVO TAL COMO HIDROCLOROTIAZIDA, FUROSEMIDA, ACETAZOLAMIDA, ENTRE OTROS; E) SALES TALES COMO CITRATO DE MAGNESIO, CITRATO DE POTASIO, BICARBONATO DE POTASIO, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE LA FORMA FARMACEUTICA ORAL SOLIDA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/565,846 US20080131504A1 (en) | 2006-12-01 | 2006-12-01 | Short Term Slow Release Drug Delivery System |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081197A1 true PE20081197A1 (es) | 2008-10-03 |
Family
ID=39493652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001676A PE20081197A1 (es) | 2006-12-01 | 2007-11-29 | Sistema de liberacion lenta a corto plazo de drogas |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080131504A1 (es) |
| AR (1) | AR064090A1 (es) |
| CL (1) | CL2007003451A1 (es) |
| PE (1) | PE20081197A1 (es) |
| TW (1) | TW200829287A (es) |
| WO (1) | WO2008070495A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2967576B1 (fr) * | 2010-11-18 | 2013-07-12 | Advicenne Pharma | Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament |
| EP2900222B1 (en) * | 2012-09-27 | 2017-06-14 | United Laboratories, Inc. | Method for producing extended-release potassium citrate wax matrix tablet |
| AU2013344654B2 (en) | 2012-11-14 | 2017-06-22 | Abon Pharmaceuticals, Llc | Oral transmucosal drug delivery system |
| JP6164507B2 (ja) * | 2013-02-28 | 2017-07-19 | ユナイテッド・ラボラトリーズ・インコーポレイテッド | 高投与量の徐放性クエン酸カリウムワックスマトリックスタブレット |
| WO2016159897A1 (en) | 2015-04-01 | 2016-10-06 | Ay Doğan | Potassium citrate suspension |
| WO2016159898A1 (en) | 2015-04-01 | 2016-10-06 | Ay Doğan | Slow release composition comprising potassium citrate and magnesium citrate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
| US4888182A (en) * | 1983-04-11 | 1989-12-19 | Board Of Regents Of The University Of Texas System | Compositions and methods of treating calcium renal stones |
| US4882167A (en) * | 1983-05-31 | 1989-11-21 | Jang Choong Gook | Dry direct compression compositions for controlled release dosage forms |
| EP0744941B1 (en) * | 1994-02-16 | 2003-06-04 | Abbott Laboratories | Process for preparing fine particle pharmaceutical formulations |
| US5741520A (en) * | 1995-10-06 | 1998-04-21 | Southland, Ltd. | Disinfectant effervescent tablet formulation |
| AU2004237131B2 (en) * | 2003-05-08 | 2009-09-10 | Nektar Therapeutics | Particulate materials |
| US20050220865A1 (en) * | 2004-04-02 | 2005-10-06 | Koleng John J | Compressed composition comprising magnesium salt |
-
2006
- 2006-12-01 US US11/565,846 patent/US20080131504A1/en not_active Abandoned
-
2007
- 2007-11-22 TW TW096144338A patent/TW200829287A/zh unknown
- 2007-11-28 WO PCT/US2007/085732 patent/WO2008070495A2/en not_active Ceased
- 2007-11-29 PE PE2007001676A patent/PE20081197A1/es not_active Application Discontinuation
- 2007-11-30 CL CL200703451A patent/CL2007003451A1/es unknown
- 2007-11-30 AR ARP070105370A patent/AR064090A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008070495A3 (en) | 2008-10-23 |
| TW200829287A (en) | 2008-07-16 |
| WO2008070495A2 (en) | 2008-06-12 |
| US20080131504A1 (en) | 2008-06-05 |
| AR064090A1 (es) | 2009-03-11 |
| CL2007003451A1 (es) | 2008-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081197A1 (es) | Sistema de liberacion lenta a corto plazo de drogas | |
| PE20130063A1 (es) | Formulaciones orales y sales lipofilicas de metilnaltrexona | |
| JP2013523677A5 (es) | ||
| BR0213175A (pt) | Forma galênica oral macroparticular para a liberação retardada e controlada de princìpios ativos farmacêuticos | |
| CR20130215A (es) | Bloques esfèricos para limpieza de inodoros, sobre la base de tensioactivos aniònicos | |
| JP2010047612A5 (es) | ||
| AR083422A1 (es) | Composiciones y metodos para tratar la hipertension pulmonar | |
| MXPA05007643A (es) | Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo. | |
| CO6680640A2 (es) | Uso de aglutinantes para fabircar formulaciones estables al almacenamiento | |
| AR044131A1 (es) | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad | |
| AR077864A1 (es) | Microgranulos flotantes | |
| BR112012008317A2 (pt) | produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal | |
| CL2009001766A1 (es) | Composicion farmaceutica solida para administracion oral que comprende: un taxano sustancialmente amorfo definido, un portador hidrofilico definido y un tensoactivo definido; metodo para preparar la composicion; y su uso para tratar una enfermedad neoplasica. | |
| AR076864A1 (es) | Procedimiento y composicion para mejorar la absorcion de agentes terapeuticos | |
| ECSP10010588A (es) | Formulacion de medicamento solida con liberacion retardada | |
| CA2644848A1 (en) | Compositions and methods for enhancing the antioxidant status of animals | |
| MY160652A (en) | Pharmaceutical composition for oral administration | |
| NZ602441A (en) | A fast dissolving pharmaceutical composition | |
| HRP20120545T1 (hr) | Farmaceutski oblici sa poboljšanim farmakokinetičkim svojstvima | |
| ECSP11011286A (es) | Formulaciones orales sólidas de una pirido-pirimidinona | |
| PE20091900A1 (es) | Una formulacion farmaceutica solida | |
| EA201070806A1 (ru) | Состав медленного высвобождения на основе ассоциации гликогена и альгината | |
| AR051589A1 (es) | Agentes terapeuticos | |
| HRP20211761T1 (hr) | Dvokomponentna kompozicija koja sadrži acetilsalicilnu kiselinu | |
| HRP20230762T1 (hr) | Nalmefen za smanjenje konzumacije alkohola u specifičnim ciljnim populacijama |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |